Clinical Trials Browser

Terminated × Melanoma × Sunitinib × Clear all

NCT01216657 2013-06-04

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Phase 2 Terminated

Melanoma

NCT00496223 2011-02-23

A Phase I/II Study of Sunitinib and Dacarbazine

Phase 1/2 Terminated

Melanoma

NCT00304200 2009-02-05

Temodar and Sutent as Therapy for Melanoma

Phase 1/2 Terminated

Melanoma